Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial

AIMS: Co-primary objectives were to evaluate dalcetrapib (JTT-705/RO4607381), which targets cholesteryl ester transfer protein (CETP), effects on high-density lipoprotein cholesterol (HDL-C) in participants with coronary heart disease or risk equivalents and to evaluate potential changes in mesenter...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Stein, Evan A., Roth, Eli M., Rhyne, James M., Burgess, Tracy, Kallend, David, Robinson, Jennifer G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2010
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2821630/
https://ncbi.nlm.nih.gov/pubmed/20097702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehp601
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi